Vectura Group plc (VEC.L)
-LSE 90.00 
3.50(3.74%) May 17, 11:35AM EDT
| Prev Close: | 93.50 |
|---|
| Open: | 94.50 |
|---|
| Bid: | 89.75 |
|---|
| Ask: | 90.25 |
|---|
| 1y Target Est: | 129.75 |
|---|
| Beta: | N/A |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 90.00 - 95.31 |
|---|
| 52wk Range: | 61.00 - 98.50 |
|---|
| Volume: | 641,203 |
|---|
| Avg Vol (3m): | 462,868 |
|---|
| Market Cap: | 300.64M |
|---|
| P/E (ttm): | N/A |
|---|
| EPS (ttm): | N/A |
|---|
| Div & Yield: | N/A (N/A) |
|---|
Quotes delayed, except where indicated otherwise. Currency in GBp.
Key Statistics
| Forward P/E (1 yr): | 1.14 |
|---|
| P/S (ttm): | 1,080.72 |
|---|
| Ex-Dividend Date: | N/A |
|---|
Analysts
| Annual EPS Est
(Mar-13)
: | -1.25 |
|---|
| Quarterly EPS Est
(Mar-13)
: | N/A |
|---|
| Mean Recommendation*: | 1.4 |
|---|
| PEG Ratio (5 yr expected): | N/A |
|---|
Business Summary
Vectura Group plc develops inhaled therapies primarily for the treatment of respiratory diseases. Its products target various diseases, such as asthma and chronic obstructive pulmonary disease (COPD).
View More